Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20553481 | 0.90 | PPARG (1.00) | PPARGPPARA | |
| SCHEMBL6556100 | 0.90 | PPARG (0.73) | PPARGPPARA | |
| SCHEMBL20553479 | 0.90 | PPARG (1.00) | PPARGPPARA | |
| SCHEMBL20553475 | 0.88 | PPARG (1.00) | PPARGPPARA | |
| SCHEMBL9818821 | 0.88 | PPARG (0.76) | PPARGPPARA | |
| SCHEMBL20553473 | 0.88 | PPARG (1.00) | PPARGPPARA | |
| SCHEMBL6713386 | 0.87 | PPARG (1.00) | PPARGPPARA | |
| SCHEMBL11059661 | 0.87 | PPARG (0.68) | PPARGPPARA | |
| SCHEMBL21068011 | 0.87 | PPARG (1.00) | PPARGPPARA | |
| SCHEMBL21068010 | 0.87 | PPARG (1.00) | PPARGPPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021021927-A1 | COMPOSITIONS AND METHODS FOR TREATING PULMONARY EDEMA OR LUNG INFLAMMATION | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 2021-02-04 | — | — | WO | claimed |
| US-5117038-A | HERBICIDAL SUBSTITUTED PHENOXYPHENYLPROPIONIC ACID DERIVATIVES | BAYER AKTIENGESELLSCHAFT (DE) | 1992-05-26 | — | — | US | claimed |
| EP-0313908-A2 | Halogen-substituted phenoxyphenylpropionic acid derivatives | BAYER AG (DE) | 1989-05-03 | — | — | EP | claimed |
| JP-51136644-A | — | — | None | — | — | JP | disclosed |
| US-20220304957-A1 | ANTI-CANCER COMPOSITIONS AND METHODS OF USE | UNIV LOUISIANA STATE (US) | 2022-09-29 | — | — | US | disclosed |
| CN-112316206-B | Implants containing resorbable metal materials and methods of making the same | 中南大学湘雅三医院 | 2022-09-02 | — | — | CN | disclosed |
| CN-112316206-A | Implants containing resorbable metallic materials and methods of making same | 中南大学湘雅三医院 | 2021-02-05 | — | — | CN | disclosed |
| WO-2021021927-A1 | COMPOSITIONS AND METHODS FOR TREATING PULMONARY EDEMA OR LUNG INFLAMMATION | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 2021-02-04 | — | — | WO | disclosed |
| CN-112188887-A | Methods and compositions for targeted delivery of active agents and immunomodulators to lymph nodes | 免疫疫苗技术公司 | 2021-01-05 | — | — | CN | disclosed |
| WO-2020146876-A2 | ANTI-CANCER COMPOSITIONS AND METHODS OF USE | BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE (US) | 2020-07-16 | — | — | WO | disclosed |
| EP-3294718-B1 | NEW DIFLUOROKETAMIDE DERIVATIVES | HOFFMANN LA ROCHE (CH) | 2020-04-29 | — | — | EP | disclosed |
| EP-0166186-A2 | Derivatives of substituted phenoxyphenyl-propionic acid | BAYER AG (DE) | 1986-01-02 | — | — | EP | disclosed |
| EP-0166186-A2 | Derivatives of substituted phenoxyphenyl-propionic acid | BAYER AG (DE) | 1986-01-02 | — | — | EP | disclosed |
| EP-0001064-B1 | FLUOROSUBSTITUTED PHENOXYBENZYL-OXYCARBONYLDERIVATIVES, -ALCOHOLS AND -HALIDES, PROCESSES FOR THEIR PREPARATION AND THEIR APPLICATION | BAYER AG (DE) | 1982-07-07 | — | — | EP | disclosed |
| EP-0000345-B1 | SUBSTITUTED PHENOXYBENZYLOXYCARBONYL DERIVATIVES, THEIR PREPARATION AND THEIR USE AS INSECTICIDES AND ACARICIDES | BAYER AG (DE) | 1981-04-01 | — | — | EP | disclosed |
| US-4242357-A | INSECTICIDES, MITICIDES | BAYER AKTIENGESELLSCHAFT (DE) | 1980-12-30 | — | — | US | disclosed |
| EP-0001064-A2 | Fluorosubstituted phenoxybenzyl-oxycarbonylderivatives, -alcohols and -halides, processes for their preparation and their application | BAYER AG (DE) | 1979-03-21 | — | — | EP | disclosed |
| EP-0000345-A1 | Substituted phenoxybenzyloxycarbonyl derivatives, their preparation and their use as insecticides and acaricides | BAYER AG (DE) | 1979-01-24 | — | — | EP | disclosed |
| JP-S51136644-A | PROCESS FOR PREPARING META-SUBSTITUTED-PHENOXYPHENYLPROPIONIC ACID DER IVATIVES | EISAI CO LTD | 1976-11-26 | — | — | JP | disclosed |
| US-3937700-A | Novel 1,2-methylene-17α-acyloxy (or improved hydroxy)-9β, 10α-steroid compounds of the pregnane series, pharmaceutic preparations on the basis of the novel compounds and methods of producing said compounds and preparations | U.S. PHILIPS CORPORATION (US) | 1976-02-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220304957-A1 | ANTI-CANCER COMPOSITIONS AND METHODS OF USE | H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, TP53, MCL1 | PPARG 1337/4885PPARA 1460/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.